Probiotic solid beverage for relieving or treating irritable bowel syndrome

Abstract

The invention discloses a probiotic solid beverage for relieving or treating irritable bowel syndrome. The product is prepared by mixing strains with excellent probiotic properties. A bacterial strainin the product comprises lactobacillus casei Zhang, bifidobacterium animalis subsp lactis V9, and lactobacillus plantarum P-8. The method comprises a step of carrying out correlation analysis on intestinal flora and activity index scores (IBSDAI) of patients of irritable bowel syndrome; the probiotic solid beverage can inhibit the growth of pathogenic bacteria by increasing the content of beneficial bacteria in intestinal tracts, the intestinal flora composition of patients is adjusted, and the effect of relieving or treating irritable bowel syndrome patients is achieved.

Description

technical field [0001] The application relates to the field of biotechnology, in particular to a probiotic solid drink for alleviating or treating irritable bowel syndrome. Background technique [0002] Irritable bowel syndrome (IBS) is a group of persistent or intermittent episodes characterized by abdominal pain, bloating, changes in bowel habits and / or stool properties, and lack of bowel function with abnormal gastrointestinal structure and biochemistry disordered disease. Rome III listed it as a category of functional bowel disease. The patients are mainly young and middle-aged people. The age of onset is more common between 20 and 50 years old. It is more common in women than men. It has a tendency to cluster in families and is often associated with other gastrointestinal disorders. Diseases such as functional dyspepsia coexist with concomitant. According to the properties of the stool, IBS is divided into four clinical types: diarrhea type, constipation type, mixed t...

AI Technical Summary

Problems solved by technology

In the past, antibiotic intervention is the first choice for IBS patients. It not only cannot cure IBS fundamentally, but also destroys the balance of intestinal microorganisms, resulting in a continuous decrease in patient resistance and even more complicated accompanying symptoms.

Images